AI Drug Development Strategies Speed Up COVID Drug Manufacturing 17 August 2020 An employee checks Arbidol capsules as they move along the production line at OAO Pharmstandard’s Leksredstva drug manufacturing unit in Kursk, Russia, on Friday, Aug. 16, 2013. Pharmstandard said it will offer $590 million in cash and shares for Bever Pharmaceutical Pte. Ltd. in a deal that will give Pharmstandard board member Alexander Shuster an 18.7 percent stake in Russia’s biggest drugmaker. Photographer: Andrey Rudakov/Bloomberg via Getty ImagesAs the pandemic medicines are unleashed...https://mfame.guru/ai-drug-development-strategies-speed-up-covid-drug-manufacturing/